SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.102
EU - Europa 4.663
AS - Asia 2.485
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
OC - Oceania 3
Totale 18.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.060
DE - Germania 1.872
CN - Cina 1.289
UA - Ucraina 804
SG - Singapore 661
IT - Italia 660
TR - Turchia 417
GB - Regno Unito 311
RU - Federazione Russa 307
FI - Finlandia 225
SE - Svezia 192
PL - Polonia 146
ID - Indonesia 80
FR - Francia 51
CA - Canada 37
BE - Belgio 32
NL - Olanda 14
LT - Lituania 13
BR - Brasile 11
IE - Irlanda 8
RO - Romania 8
VN - Vietnam 8
CZ - Repubblica Ceca 7
EU - Europa 6
IN - India 5
HK - Hong Kong 4
IR - Iran 4
JP - Giappone 4
DK - Danimarca 3
EC - Ecuador 3
ES - Italia 3
MX - Messico 3
CH - Svizzera 2
CY - Cipro 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
GR - Grecia 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
Totale 18.278
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.316
Fairfield 1.155
Chandler 1.111
Jacksonville 897
Houston 767
Ashburn 727
Singapore 512
Ann Arbor 506
Santa Clara 491
Wilmington 442
Seattle 432
Cambridge 359
Izmir 278
Beijing 268
Nanjing 264
Princeton 226
Addison 216
San Diego 152
Warsaw 146
New York 139
Shanghai 137
Ferrara 132
Milan 132
Boardman 113
Jakarta 80
Los Angeles 78
Shenyang 78
Hebei 70
Nanchang 70
Bremen 66
Washington 61
Dearborn 56
Helsinki 52
Changsha 48
Mountain View 46
Tianjin 46
Jiaxing 43
Munich 40
Falls Church 37
London 37
Redwood City 35
Brussels 32
Jinan 32
Kunming 30
Ningbo 24
Norwalk 23
Guangzhou 22
Bologna 20
Des Moines 18
Frankfurt am Main 18
San Mateo 18
Toronto 18
Zhengzhou 17
Orange 15
Tappahannock 15
Auburn Hills 14
Ottawa 13
Taizhou 13
Hangzhou 12
Indiana 11
Hefei 10
Philadelphia 10
Carrara 9
Dong Ket 8
Leawood 8
Monmouth Junction 8
Rome 8
Haikou 7
Lanzhou 7
Modena 7
Augusta 6
Changchun 6
Redmond 6
Brno 5
Castelnuovo Rangone 5
Falkenstein 5
Ferrara di Monte Baldo 5
Verona 5
Walnut 5
Amsterdam 4
Ardabil 4
Chicago 4
Dallas 4
Hong Kong 4
Lappeenranta 4
Padova 4
San Francisco 4
Stockholm 4
Treviso 4
Alberobello 3
Bari 3
Cattolica 3
Cordovado 3
Dublin 3
Fuzhou 3
Hounslow 3
Jinhua 3
Lusia 3
Napoli 3
Paris 3
Totale 12.429
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 240
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 164
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 159
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 157
Circadian profile of plasma calcitonin gene-related peptide in healthy man 154
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 154
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 142
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 141
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 139
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 138
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 134
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 133
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 132
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 131
null 130
Pituitary side effects of old and new drugs. 125
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 125
Cerebral aneurysm and acromegaly: a case report 124
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 122
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 121
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 121
In vitro testing of new somatostatin analogs on pituitary tumor cells 119
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 119
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 119
null 118
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 118
Growth hormone and skeletal muscle function 115
null 114
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 114
null 113
Growth hormone excess promotes breast cancer chemoresistance 113
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 112
null 111
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 111
null 111
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 110
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 109
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 109
null 108
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 107
null 106
null 106
null 106
null 105
Le alterazioni pressorie nell'acromegalia: fattori umorali 104
null 104
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 103
null 103
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 103
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 102
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 102
null 102
null 102
null 102
null 101
null 101
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 101
null 100
null 100
Diurnal rhythm of plasma catecholamines in acromegaly 99
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 98
null 98
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 98
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 97
Growth hormone induces chemoresistance in breast cancer cells 97
null 97
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 96
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 96
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 95
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 95
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 95
Antiproliferative effects of somatostatin analogs in pituitary adenomas 94
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 94
Ovarian tumors secreting insulin 93
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 93
null 92
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 92
Prevalence of hypopituitarismin patients with cerebrovascular diseases 91
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 91
null 91
Delta opioid receptor involvement in endocrine pathophysiology 90
Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications 90
Glucose metabolism alterations in acromegaly 89
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 88
null 88
Effects of octreotide on gallbladder motor function in acromegaly 88
Cerebrovascular disease and GH-IGF-i axis function 88
null 88
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 87
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 87
Pattern of Growth Hormone secretion in closed head injured patients 87
Functional hypothalamic and drug-induced amenorrhea: an overview 87
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 86
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 86
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 86
Systemic illness 85
Occurrence of pituitary dysfunction following traumatic brain injury 85
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 85
null 85
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 85
Totale 10.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.717
Totale 97.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.955 0 0 0 0 184 397 235 308 210 375 195 51
2020/20212.021 187 145 119 256 72 212 64 235 66 269 288 108
2021/20221.981 58 208 114 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/20251.533 157 149 427 183 617 0 0 0 0 0 0 0
Totale 18.566